Shalev Fried
Impact in
- Oncology top 10%
- CAR-T cell therapy research
-
- Virus-based gene therapy research
Papers in
- Oncology 13
- CAR-T cell therapy research 12
-
- Neonatal and fetal brain pathology 4
- Fetal and Pediatric Neurological Disorders 4
- Prenatal Screening and Diagnostics 3
- Co-authors
- Arnon Nagler (16 shared papers)Avichai Shimoni (14 shared papers)Elad Jacoby (10 shared papers)Abraham Avigdor (12 shared papers)Michal J. Besser (6 shared papers)Amilia Meir (1 shared paper)Amos Toren (1 shared paper)Bella Bielorai (1 shared paper)
- Journals
- Blood (4 papers)Bone Marrow Transplantation (3 papers)Blood Advances (2 papers)American Journal of Neuroradiology (2 papers)Hematological Oncology (2 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Shalev Fried
21 papers receiving 387 citations
Peers
Comparison fields: 5 of 47
- Oncology 313
- Genetics 134
- Hematology 41
- Otorhinolaryngology 16
- Periodontics 13
Countries citing papers authored by Shalev Fried
This map shows the geographic impact of Shalev Fried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalev Fried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalev Fried more than expected).
Fields of papers citing papers by Shalev Fried
This network shows the impact of papers produced by Shalev Fried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalev Fried. The network helps show where Shalev Fried may publish in the future.
Co-authors
The 25 scholars most cited alongside Shalev Fried, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 258 | |
| 2 | 2020 | 42 | |
| 3 | 2022 | 24 | |
| 4 | 2020 | 23 | |
| 5 | 2024 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2020 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2019 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2023 | 1 |
About Shalev Fried
Shalev Fried is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Electrical and Electronic Engineering, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 390 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Neonatal and fetal brain pathology (4 papers), Integrated Circuits and Semiconductor Failure Analysis (4 papers), Salivary Gland Disorders and Functions (4 papers), Oral health in cancer treatment (4 papers), Fetal and Pediatric Neurological Disorders (4 papers), Prenatal Screening and Diagnostics (3 papers) and Pregnancy and preeclampsia studies (3 papers). The work is most often cited by research in Oncology (313 citations), Genetics (134 citations), Hematology (41 citations), Otorhinolaryngology (16 citations) and Periodontics (13 citations). Shalev Fried has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Arnon Nagler, Avichai Shimoni, Elad Jacoby, Abraham Avigdor, Michal J. Besser, Amilia Meir, Amos Toren, Bella Bielorai, Jacob Schachter and Roni Shouval. Their work appears in journals such as Blood, Bone Marrow Transplantation, Blood Advances, American Journal of Neuroradiology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.